Granulox^® is an oxygenating spray for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, arterial leg ulcers, mixed leg ulcers and for the secondary healing of surgical wounds and pressure sores⁽¹⁾. Granulox^® can also be used on sloughy and infected wounds.⁽²⁾ The oxygen supply to the base of the wound supports wound healing and patient outcomes.⁽³⁾

When Granulox^® is sprayed on a wound, highly purified haemoglobin is released. This binds with oxygen from the environment and diffuses through the wound exudate, and the haemoglobin supplies the base of the wound topically with oxygen. The oxygen supply to the base of the wound supports wound healing and patient outcomes.⁽³⁾

A convenient spray application makes Granulox^® a portable and easy-to-use adjunct to standard of care wound treatment. Granulox^® can be applied when the wound dressing is changed, and at least every three days for optimal results.

Studies report that using Granulox^® results in shorter healing time, reduced pain scores and total cost savings for healthcare providers compared to standard of care.⁽³⁾

• Twice as many chronic wounds healed at 8–16 weeks compared to standard of care⁽¹⁾
• Time to heal diabetic foot ulcers 50% shorter than with standard of care ⁽²⁾
• Treatment costs in diabetic foot ulcers at least 40% lower than with standard of care
• More than 70% of patients reported lower average pain scores at four weeks than with standard of care in chronic wounds ⁽³⁾
• 99% less slough in chronic wounds after 4 weeks compared to 33% with standard of care

Haemoglobin spray

References:

1. Hunt SD, Elg F. Hemoglobin spray as adjunct therapy in complex wounds: Meta-analysis versus standard care alone in pooled data by wound type across three retrospective cohort controlled evaluations. SAGE Open Medicine, 2018; 6:1-9.
2. Hunt SD, Elg F. Clinical effectiveness of hemoglobin spray (Granulox) as adjunctive therapy in the treatment of chronic diabetic foot ulcers. November 2016.
3. Dissemont J, Kröger K, Storck M, Risse A, Engels P. Topical oxygen wound therapies for chronic wounds: a review. Journal of Wound Care, 2015, Feb, 24(2);53-63.

Granudacyn^® is an irrigation solution for cleansing and moisturising acute, chronic and contaminated wounds, as well as for first and second degree burns. In addition, the product can be applied on CNS tissue, cartilage and bone and is well suited for cavities and fistulas.

Hypochlorous acid (HOCl) ensures safe preservation of tissue making Granudacyn^® a reliable wound irrigation solution. Granudacyn^® is suitable for multi-patient use of up to 90 days (gel) and 60 days (solution) after opening. To ensure safe use after opening, Granudacyn^® contains a preservative that naturally occurs in the body: hypochlorous acid ⁽¹⁾. Hypochlorous acid also prevents the proliferation of Gram+ and Gram- bacteria including MRSA, ORSA, VRSA, VRE, viruses, fungi and spores.

Available in solution, spray, gel and NPWT format.

References

1. Consensus on Wound Antisepsis: Update 2018, Skin Pharmacol Physiol 2018;31:28–58, DOI: 10.1159/000481545.

Mepilex foams and bordered foams with Safetac^® technology minimise pain and trauma at dressing changes with gentle adherence and can stay on wounds for up to seven days depending on the condition of the wound or as indicated by accepted clinical protocols.

Depending on the challenge you’re facing, Mepilex dressings are available in an assortment of shapes with and without borders for a variety of wounds.

Dressings available in our foam portfolio with Safetac^® technology include:

The Mölnlycke portfolio has a wide range of silver antimicrobial dressings with Safetac^® technology which result in shorter healing times, shorter hospital stays, fewer dressing changes, a reduced need for analgesia during dressing changes and reduced bioburden. Mölnlycke antimicrobial dressings improve patient and economic outcomes.
The safetac^® silver dressings act as an antimicrobial barrier for acute or chronic infected wounds as well as wounds at high risk of infection or re-infection with antimicrobial efficacy for up to 7 - 8 days⁽¹⁾ This may include burns, surgical wounds or wounds in patients who are immunocompromised or have poor circulation.

Dressings available in our Safetac^® silver antimicrobial portfolio include:

Mepilex Border Post-Op is an advanced post-operative dressing designed to ensure effective protection of the surgical site, reducing post-op complications which influence costly hospital readmissions⁽¹⁾ The unique flex-cut core stretches in all directions and conforms to the body as it moves, supporting early patient mobilisation.⁽²⁾

Mepilex Surgical absorbs more than any other current dressing on the market^(3-6), has a shower proof seal and bacterial barrier and the transparent border allows inspection of the peri-wound skin without removing the dressing.

Dressings available in the portfolio:

Mepitel is a soft silicone transparent perforated and non-absorbent dressing with Safetac^® technology, minimising pain to the patient and trauma to the wound and the surrounding skin at dressing removal^(1-4)
The open mesh structure allows exudate to pass into a secondary absorbent dressing. This reduces frequent dressing changes and supports undisturbed wound healing.

Mepitel has been clinically proven for effective use in treating a wide range of wounds such as skin tears, skin abrasions, sutured wounds, partial thickness burns, lacerations, partial and full thickness grafts, diabetic ulcers, venous and arterial ulcers

Products include:

Mepiform^® is a gentle self-adherent scar dressing with soft silicone for scar management. It is designed for the management of hypertrophic and keloid scars It can also be used as prophylactic therapy on closed wounds for the prevention of scarring and keloid formation.

Mepiform testimonial prof Klaus Eisendle

Unlike more traditional gelling fibres, Exufiber^® is a non-woven PVA dressing. It transforms into a gel upon contact with exudate, helping it to softly conform to the wound bed. Exufiber can be used to treat a wide range of medium to highly exuding wounds, including cavity wounds.
Exufiber is made with Hydrolock^® Technology to both absorb exudate and keep it locked into the fibres. Exufiber reduces the risk of leakage and maceration, helping to create an optimal healing environment. Hydrolock^® Technology allows the dressing to stay intact when wet, without the need for further reinforcement, making it easy to remove in one piece during dressing changes.^(1,2,3)

Products available in the portfolio:

• Exufiber
• Exufiber Ag
• Exufiber Ribbon

Exufiber in practice